ANGO241220P5000
- 0.05
- 0.000.00%
AngioDynamics Newsroom
AngioDynamics Shareholder Approvals and Director Elections
Fresenius Medical Q3 Earnings Beat Estimates, Operating Margin Rises
Tempus Stock Declines Despite Q3 Earnings & Revenues Beat Estimates
Wall Street Analysts Believe AngioDynamics (ANGO) Could Rally 94.32%: Here's Is How to Trade
Investors in AngioDynamics (NASDAQ:ANGO) Have Unfortunately Lost 77% Over the Last Three Years
AngioDynamics Stock Plunges 13.8% in Three Months: What's Next?
ANGO Stock Rises Following the Receipt of CPT Category I Code for IRE
CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $12
Express News | AngioDynamics, University College London Hospital Launch International Multi-Center Study On Long Term Effects Of Treatment With NanoKnife System
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Otsuka Holdings Co (OtherOTSKF) and AngioDynamics (ANGO)
AngioDynamics and UCLH Launch Study of 'Long Term Effects' of NanoKnife System
AngioDynamics' NanoKnife System Gains CPT Codes for Prostate and Liver Treatments
AngioDynamics Announces American Medical Association's CPT Editorial Panel Grants Category I CPT for Irreversible Electroporation (IRE) in Prostate and Liver
CEO, President & Director of AngioDynamics James Clemmer Buys 4.4% More Shares
Insider Trading Activity Heats Up: Tuesday's Top Buys and Sells in US Stocks
AngioDynamics (NASDAQ:ANGO Shareholders Incur Further Losses as Stock Declines 20% This Week, Taking Three-year Losses to 76%
AngioDynamics Reports Q1 Adjusted EPS (11c), Consensus (15c)
Oppenheimer Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $13
AngioDynamics Stock Up on Q1 Earnings Beat, Y/Y Pro-Forma Sales Rise
AngioDynamics Is Maintained at Buy by Canaccord Genuity